REGN 240802 1000.00P (REGN240802P1000000) Stock Options, News & Quotes

5.95
+0.38+6.82%

15min DelayClose Jul 31 16:00 ET

5.95High3.60Low

SymbolStock Name

Latest PriceChg% ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D % Chg10D % Chg20D % Chg60D % Chg120D % Chg250D % Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry

WatchlistPaper Trade

Comments

Meltyy

Jun 12 08:00

$Regeneron Pharmaceuticals(REGN.US)$
🔔 FDA Approves Kevzara® (sarilumab)
» for Treatment of Active Polyarticular Juvenile Idiopathic Arthritis (pJIA) 🦴
» sBLA approval in patients with pJIA weighing ≥ 63kg
» adds to Kevzara’s position in treating adult chronic inflammatory conditions of moderately to severely active rheumatoid arthritis & polymyalgia rheumatica

Meltyy

Jun 11 03:48

🔔 FDA PDUFA Update…

🚨 1 AdCom & 3 PDUFA decisions this week:
$Genfit(GNFT.US)$ & $IPSEN SA SPONS ADR EA REPR 0.25 ORD(IPSEY.US)$ : 🤔
⇨ Elafibranor
‣ Primary biliary cholangitis
‣ PDUFA date: 6/10/24
$Regeneron Pharmaceuticals(REGN.US)$ : 🤔
⇨ Kevzara (sarilumab)
‣ Polyarticular juvenile idiopathic arthritis
‣ PDUFA date: 6/10/24
$Bristol-Myers Squibb(BMY.US)$ : 🤔
⇨ Augtyro™ (Repotrectinib)
‣ PDUFA date: 6/15/24 (sNDA)
🗓️ Last week’s PDUFAs:
$GlaxoSmithKline(GSK.US)$ : Approved 6/7 🎉
⇨ Arexvy
‣ Respiratory s...

Meltyy

Jun 7 03:39

🚨 June PDUFAs

» 15+ upcoming FDA decisions to watch: 👀 👇
$GlaxoSmithKline(GSK.US)$ : Arexvy
$Genfit(GNFT.US)$ & $IPSEN SA SPONS ADR EA REPR 0.25 ORD(IPSEY.US)$ : Elafibranor
$Eli Lilly and Co(LLY.US)$ : Donanemab - AdCom meeting 🗓️
$Regeneron Pharmaceuticals(REGN.US)$ : Kevzara (sarilumab)
$Bristol-Myers Squibb(BMY.US)$ : Augtyro™ (Repotrectinib)
$Geron(GERN.US)$ : Imetelstat
$Merck & Co(MRK.US)$ : V116
$Amgen(AMGN.US)$ : BLINCYTO (blinatumomab)
$Sarepta Therapeutics(SRPT.US)$ : ELEVIDYS
$Merck & Co(MRK.US)$ : KEYTRUDA ...

Moomoo News Global

Jun 5 01:01

Columns Nvidia's Upcoming Stock Split: What Investors Need to Know

Nvidia announced its sixth stock split, with shares set to trade at one-tenth their current price starting June 10, 2024. Before the Q1 2024 earnings call on May 22, when the split was revealed, NVDA closed at $949.50. Since then, the stock has surged past the $1,150 mark, reaching all-time highs. To be eligible for the split shares, investors must own the stock by the market close at 4 pm ET on June 6, 2024. Nvidia's last 4-for-1 split i...

Nvidia's 2024 AGM highlights: Pay packages and new AI market strategies

330

Moomoo News Global

May 27 05:45

Columns Nvidia's Stock Split Could Spur Peer Moves in Tech; Potential Followers Listed

Nvidia delighted investors when it announced a 10-for-1 stock split last week. The move may be the start of a trend, as several prominent tech companies trade at prices high enough to tip the scales toward similar splits, according to a note from Bank of America.
The bank highlights 36 S&P 500 companies with stock prices above $500, a level suggesting they may be candidates for splits. $Broadcom(AVGO.US)$, $Super Micro Computer(SMCI.US)$ , ...

Nvidia's 2024 AGM highlights: Pay packages and new AI market strategies